Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$1.02B |
| 2 |
Canadian Natural Resources
CNQ
|
+$958M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$896M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$861M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$756M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.62B |
| 2 |
Amgen
AMGN
|
+$1.68B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.18B |
| 4 |
Visa
V
|
+$1.05B |
| 5 |
Invesco QQQ Trust
QQQ
|
+$1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Healthcare | 9.32% |
| 3 | Financials | 8.97% |
| 4 | Consumer Discretionary | 7.33% |
| 5 | Industrials | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4726
Bausch + Lomb
BLCO
$5.84B
| $556K | ﹤0.01% |
35,851
+15,569
| +77% | +$234K |
|
4727
Full House Resorts
FLL
$79.4M
| $553K | ﹤0.01% |
73,548
+49,033
| +200% | +$339K |
|
4728
WisdomTree US LargeCap Fund
EPS
$1.64B
| $553K | ﹤0.01% |
+13,299
| New | +$553K |
|
4729
First Trust Nasdaq Pharmaceuticals ETF
FTXH
$922M
| $550K | ﹤0.01% |
20,039
| – | – |
|
|
DSKE
4730
DELISTED
Daseke, Inc. Common Stock
DSKE
| $549K | ﹤0.01% |
96,402
+6,603
| +7% | +$39K |
|
|
SUNL
4731
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
| $548K | ﹤0.01% |
21,257
+11,848
| +126% | +$328K |
|
4732
Alkami Technology
ALKT
$2.11B
| $548K | ﹤0.01% |
37,567
-13,581
| -27% | -$189K |
|
4733
CALL
Bath & Body Works
BBWI
$4.06B
| $548K | ﹤0.01% |
+13,000
| New | +$485K |
|
4734
Invesco MSCI USA ETF
PBUS
$11.7B
| $547K | ﹤0.01% |
14,372
| – | – |
|
4735
Esquire Financial Holdings
ESQ
$1.14B
| $546K | ﹤0.01% |
12,623
+122
| +1% | +$5.17K |
|
4736
iShares Genomics Immunology and Healthcare ETF
IDNA
$198M
| $540K | ﹤0.01% |
21,449
+9,719
| +83% | +$261K |
|
4737
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$311M
| $540K | ﹤0.01% |
2,421
+966
| +66% | +$221K |
|
|
NYXH
4738
Nyxoah
NYXH
$131M
| $540K | ﹤0.01% |
108,172
+57,790
| +115% | +$328K |
|
|
LONA
4739
LeonaBio Inc
LONA
$73.4M
| $539K | ﹤0.01% |
17,000
+1,030
| +6% | +$32.5K |
|
|
BCOV
4740
DELISTED
Brightcove, Inc.
BCOV
| $537K | ﹤0.01% |
102,660
-147,990
| -59% | -$863K |
|
4741
Cato Corp
CATO
$65.9M
| $536K | ﹤0.01% |
57,453
+29,450
| +105% | +$301K |
|
4742
Goldman Sachs ActiveBeta Europe Equity ETF
GSEU
$126M
| $535K | ﹤0.01% |
17,940
+309
| +2% | +$8.72K |
|
4743
CALL
RTX Corp
RTX
$301B
| $535K | ﹤0.01% |
+5,300
| New | +$499K |
|
4744
PUT
Altria Group
MO
$113B
| $535K | ﹤0.01% |
11,700
-9,100
| -44% | -$412K |
|
|
PAMT
4745
PAMT Corp
PAMT
$315M
| $534K | ﹤0.01% |
20,634
-627
| -3% | -$17.9K |
|
|
SEVN
4746
Seven Hills Realty Trust
SEVN
$175M
| $534K | ﹤0.01% |
58,782
+15
| +0% | +$140 |
|
|
CBAY
4747
DELISTED
Cymabay Therapeutics
CBAY
| $534K | ﹤0.01% |
85,214
-149,508
| -64% | -$568K |
|
4748
Vivid Seats
SEAT
$88.6M
| $533K | ﹤0.01% |
3,648
-8,240
| -69% | -$1.28M |
|
4749
Tilly's
TLYS
$126M
| $530K | ﹤0.01% |
58,576
-1,178
| -2% | -$10.3K |
|
4750
FTC Solar
FTCI
$44M
| $529K | ﹤0.01% |
19,756
-18,860
| -49% | -$447K |
|
Similar funds
Goldman Sachs's Q4 2022 Portfolio in Review
As of Q4 2022, Goldman Sachs held 6,669 positions worth $408B, up 3.1% from $396B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $13.2B in Q4 2022, closing 721 positions and reducing 2,588 holdings. Its most notable exit was ChemoCentryx, Inc., an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Perfect Corp worth $104M.
- Goldman Sachs's largest Q4 2022 buy was Perfect Corp: 14,518,235 shares worth $104M.
- Goldman Sachs added most to Vanguard Total Bond Market in Q4 2022, an estimated $1.02B increase.
- Goldman Sachs's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.62B.
- Goldman Sachs fully exited ChemoCentryx, Inc. in Q4 2022, selling an estimated $290M.
- Goldman Sachs's ten largest holdings make up 15% of its $408B portfolio in Q4 2022.
- Goldman Sachs opened 429 new positions and closed 721 in Q4 2022.
- Goldman Sachs's portfolio value rose 3.1% quarter-over-quarter to $408B.
Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.